Renal involvement in mixed connective tissue disease: a longitudinal clinicopathologic study.

Eleven of 30 patients with MCTD, followed for a mean of 10 years, developed immune complex nephropathy (five membranous, two mesangial, one mixed, and one sclerosing) with NS in nine of 11. Another patient had membranous nephropathy at autopsy. Patients with renal disease tended to have more systemic manifestations than those without. NS was at times of abrupt onset, recurrent, and/or persistent. Anti-RNP and serum complement were not helpful in predicting nephritis. Seventy-two percent of nephropathy and 62% of NS episodes resolved or improved after corticosteroid therapy. Five patients became hypertensive, two developed chronic renal failure and required chronic dialysis, and one needed acute dialysis twice. One patient progressed to focal proliferative crescentic nephritis with necrotizing arteritis. Three patients with nephropathy died, two of pulmonary hypertension with acute cor pulmonale and one of overwhelming sepsis. Nephropathy is relatively common in MCTD, is associated with substantial morbidity, and with the risk of hypertension and chronic renal failure.
AuthorsR C Kitridou, M Akmal, S B Turkel, G R Ehresmann, F P Quismorio Jr, S G Massry
JournalSeminars in arthritis and rheumatism (Semin Arthritis Rheum) Vol. 16 Issue 2 Pg. 135-45 (Nov 1986) ISSN: 0049-0172 [Print] UNITED STATES
PMID3563525 (Publication Type: Journal Article)
Chemical References
  • Antigen-Antibody Complex
  • Autoantibodies
  • Adolescent
  • Adult
  • Antigen-Antibody Complex (analysis)
  • Autoantibodies (analysis)
  • Female
  • Humans
  • Kidney (pathology)
  • Kidney Diseases (complications, immunology, pathology)
  • Longitudinal Studies
  • Male
  • Middle Aged
  • Mixed Connective Tissue Disease (complications, immunology)
  • Proteinuria (complications)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: